Risk Markers of Arterial Aging. The Paris Prospective Study III-2

Recruiting now

Conditions studied: Arterial Stiffness

In brief

The main objectives of PPS3-2 are (i) to describe the dynamics of vascular aging and baroreflex sensitivity 12 to 16 years a part, (ii) to identify their determinants, and (iii) to quantify the subsequent risk of cardiovascular diseases.

Key facts

Study ID

NCT06079424

Run by

Institut National de la Santé Et de la Recherche Médicale, France

People needed

7500

Starts

2025-06-20

Expected to finish

2033-12-01

Last updated by the study team

2025-09-11

Who can join

Age: 60 and older, up to 95. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Being enrolled in PPS3 and having signed an informed consent for PPS3-2

You may not qualify if…

• Institutionalized participants
• Participants under guardianship
• Participants under judicial safeguard measure

Where it is running

• Centre d'Investigation Précliniques — Paris, France (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.